Works by Terpos, E.

Results: 76
    1
    2
    3
    4
    5
    6

    BONE DISEASE.

    Published in:
    2023
    By:
    • Terpos, E.
    Publication type:
    Abstract
    7
    8
    9
    10
    11

    P14 OCULAR TOXICITY IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH BELANTAMAB MAFODOTIN, LENALIDOMIDE AND DEXAMETHASONE IN A PHASE 1/2 TRIAL.

    Published in:
    HemaSphere, 2023, v. 7, p. 17, doi. 10.1097/01.HS9.0000936184.12325.62
    By:
    • Ntanasis‐Stathopoulos, I.;
    • Gavriatopoulou, M.;
    • Malandrakis, P.;
    • Fotiou, D.;
    • Kanellias, N.;
    • Migkou, M.;
    • Theodorakakou, F.;
    • Spiliopoulou, V.;
    • Syrigou, R.;
    • Eleutherakis‐Papaiakovou, E.;
    • Gkolfinopoulos, S.;
    • Manousou, K.;
    • Kastritis, E.;
    • Dimopoulos, M.A.;
    • Terpos, E.
    Publication type:
    Article
    12

    B06 HIGH LEVELS OF CIRCULATING PLASMA CELLS AT DIAGNOSIS ARE PREDICTIVE FOR WORSE PROGNOSIS IN BOTH TRANSPLANT‐ELIGIBLE AND ‐INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA.

    Published in:
    HemaSphere, 2023, v. 7, p. 6, doi. 10.1097/01.HS9.0000936116.67964.86
    By:
    • Malandrakis, P.;
    • Ntanasis‐Stathopoulos, I.;
    • Kostopoulos, I.V.;
    • Roussakis, P.;
    • Eleutherakis‐Papaiakovou, E.;
    • Panteli, C.;
    • Angelis, N.;
    • Spiliopoulou, V.;
    • Orologas‐Stavrou, N.;
    • Theodorakakou, F.;
    • Fotiou, D.;
    • Migkou, M.;
    • Gavriatopoulou, M.;
    • Kastritis, E.;
    • Tsitsilonis, O.E.;
    • Dimopoulos, M.A.;
    • Terpos, E.
    Publication type:
    Article
    13

    BONE DISEASE.

    Published in:
    HemaSphere, 2023, v. 7, p. 3, doi. 10.1097/01.HS9.0000936088.37112.16
    By:
    • Terpos, E.
    Publication type:
    Article
    14
    15

    P1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID‐19: RESULTS OF A MULTICENTER PHASE II TRIAL.

    Published in:
    HemaSphere, 2022, v. 6, p. 1510, doi. 10.1097/01.HS9.0000849372.14120.8e
    By:
    • Thomopoulos, T.;
    • Bouchla, A.;
    • Antoniadou, A.;
    • Terpos, E.;
    • Politou, M.;
    • Stamoulis, K.;
    • Koromboki, E.;
    • Papageorgiou, S.;
    • Kotanidou, A.;
    • Kalomenidis, I.;
    • Jahaj, E.;
    • Grigoropoulou, S.;
    • Pagoni, M.;
    • Grouzi, E.;
    • Poulakou, G.;
    • Trontzas, I.;
    • Labropoulou, S.;
    • Mentis, A.;
    • Bamias, A.;
    • Tsiodras, S.
    Publication type:
    Article
    16

    P1507: CLINICAL PROFILE OF COVID‐19 INFECTION AND IMMUNE RESPONSE AFTER 3AND6 MONTH VACCINATION AGAINST SARS‐COV‐2 IN ADULT PATIENTS WITH TRANSFUSION‐DEPENDENT THALASSAEMIA‐THE EXPERIENCE OF A GREEK CENTER.

    Published in:
    HemaSphere, 2022, v. 6, p. 1388, doi. 10.1097/01.HS9.0000848884.51703.0f
    By:
    • Delaporta, P.;
    • Terpos, E.;
    • Solomou, E. E.;
    • Gumeni, S.;
    • Chatzielefteriou, M.‐I.;
    • Toutoudaki, K.;
    • Kyriakopoulou, D.;
    • Ioakeimidou, N.;
    • Ntanasis‐Stathopoulos, I.;
    • Papassotiriou, I.;
    • Trougakos, I. P.;
    • Dimopoulos, M. A.;
    • Kattamis, A.
    Publication type:
    Article
    17
    18

    P22: A NON‐INTERVENTIONAL, PROSPECTIVE, OBSERVATIONAL STUDY OF RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED WITH IXAZOMIB IN REAL‐WORLD SETTINGS IN GREECE; INTERIM RESULTS OF THE 'OL‐ORAL' STUDY.

    Published in:
    HemaSphere, 2022, v. 6, p. 23, doi. 10.1097/01.HS9.0000829660.52103.dd
    By:
    • Katodritou, E;
    • Kyrtsonis, MC;
    • Delimpasi, S;
    • Spanoudakis, E;
    • Vassilopoulos, G;
    • Zikos, P;
    • Viniou, N;
    • Kaiafa, G;
    • Papathanasiou, M;
    • Pappa, V;
    • Michalis, E;
    • Adamopoulos, I;
    • Kokoviadou, K;
    • Tsirakis, G;
    • Poziopoulos, C;
    • Terpos, E
    Publication type:
    Article
    19

    P16: DARATUMUMAB MONOTHERAPY HAS A FAVORABLE EFFECT ON BONE METABOLISM IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA; RESULTS OF THE PHASE 2 REBUILD STUDY.

    Published in:
    HemaSphere, 2022, v. 6, p. 20, doi. 10.1097/01.HS9.0000829636.39178.19
    By:
    • Terpos, E;
    • Ntanasis‐Stathopoulos, I;
    • Kastritis, E;
    • Hatjiharissi, E;
    • Katodritou, E;
    • Eleutherakis‐Papaiakovou, E;
    • Verrou, E;
    • Gavriatopoulou, M;
    • Leonidakis, A;
    • Delimpasi, S;
    • Malandrakis, P;
    • Kyrtsonis, M‐C;
    • Papaioannou, M;
    • Symeonidis, A;
    • Dimopoulos, MA
    Publication type:
    Article
    20
    21

    COVID‐19 AND MYELOMA.

    Published in:
    HemaSphere, 2022, v. 6, p. 5, doi. 10.1097/01.HS9.0000829540.80501.f8
    By:
    • Ludwig, H;
    • Sonneveld, P;
    • Boccadoro, M;
    • Terpos, E
    Publication type:
    Article
    22
    23
    24

    A proposed index of diffuse bone marrow [18F]-FDG uptake and PET skeletal patterns correlate with myeloma prognostic markers, plasma cell morphology, and response to therapy.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 5, p. 1487, doi. 10.1007/s00259-020-05078-1
    By:
    • Paschali, A.;
    • Panagiotidis, E.;
    • Triantafyllou, T.;
    • Palaska, V.;
    • Tsirou, K.;
    • Verrou, E.;
    • Υiannaki, E.;
    • Markala, D.;
    • Papanikolaou, A.;
    • Pouli, A.;
    • Konstantinidou, P.;
    • Chatzipavlidou, V.;
    • Terpos, E.;
    • Katodritou, E.
    Publication type:
    Article
    25
    26

    PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB‐CHOP (RCHOP) ± RADIOTHERAPY (RT).

    Published in:
    Hematological Oncology, 2019, v. 37, p. 266, doi. 10.1002/hon.76_2630
    By:
    • Vassilakopoulos, T.P.;
    • Papageorgiou, S.G.;
    • Michail, M.;
    • Angelopoulou, M.K.;
    • Kourti, G.;
    • Kalpadakis, C.;
    • Kotsopoulou, M.;
    • Leonidopoulou, T.;
    • Konstantinidou, P.;
    • Kotsianidis, I.;
    • Boutsis, D.;
    • Michali, E.;
    • Sachanas, S.;
    • Terpos, E.;
    • Karianakis, G.;
    • Poziopoulos, C.;
    • Vadikolia, C.;
    • Pigaditou, A.;
    • Vrakidou, E.;
    • Anargyrou, K.
    Publication type:
    Article
    27

    PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB‐CHOP (RCHOP) ± RADIOTHERAPY (RT).

    Published in:
    Hematological Oncology, 2019, v. 37, p. 266, doi. 10.1002/hon.76_2630
    By:
    • Vassilakopoulos, T.P.;
    • Papageorgiou, S.G.;
    • Michail, M.;
    • Angelopoulou, M.K.;
    • Kourti, G.;
    • Kalpadakis, C.;
    • Kotsopoulou, M.;
    • Leonidopoulou, T.;
    • Konstantinidou, P.;
    • Kotsianidis, I.;
    • Boutsis, D.;
    • Michali, E.;
    • Sachanas, S.;
    • Terpos, E.;
    • Karianakis, G.;
    • Poziopoulos, C.;
    • Vadikolia, C.;
    • Pigaditou, A.;
    • Vrakidou, E.;
    • Anargyrou, K.
    Publication type:
    Article
    28
    29

    Novel treatments of multiple myeloma.

    Published in:
    Hematology, 2005, v. 10, p. 25, doi. 10.1080/10245330512331389791
    By:
    • Dimopoulos, M. A.;
    • Anagnostopoulos, A.;
    • Terpos, E.
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Hematology Quiz -- Case 24.

    Published in:
    Archives of Hellenic Medicine / Arheia Ellenikes Iatrikes, 2011, v. 28, n. 4, p. 574
    By:
    • Meletis, J.;
    • Asimakopoulos, J. V.;
    • Papageorgiou, L.;
    • Karali, V.;
    • Boutsikas, G.;
    • Petevi, K.;
    • Dalagiorgos, Th.;
    • Kanellopoulos, A.;
    • Gainarou, G.;
    • Flevari, P.;
    • Koutsi, E.;
    • Terpos, E.
    Publication type:
    Article
    41
    42

    Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension.

    Published in:
    2019
    By:
    • Bringhen, S.;
    • Milan, A.;
    • D'Agostino, M.;
    • Ferri, C.;
    • Wäsch, R.;
    • Gay, F.;
    • Larocca, A.;
    • Offidani, M.;
    • Zweegman, S.;
    • Terpos, E.;
    • Goldschmidt, H.;
    • Cavo, M.;
    • Ludwig, H.;
    • Driessen, C.;
    • Auner, H. W.;
    • Caers, J.;
    • Gramatzki, M.;
    • Dimopoulos, M. A.;
    • Boccadoro, M.;
    • Einsele, H.
    Publication type:
    journal article
    43
    44
    45
    46
    47
    48
    49

    International Myeloma Working Group recommendations for global myeloma care.

    Published in:
    Leukemia (08876924), 2014, v. 28, n. 5, p. 981, doi. 10.1038/leu.2013.293
    By:
    • Ludwig, H;
    • Miguel, J S;
    • Dimopoulos, M A;
    • Palumbo, A;
    • Garcia Sanz, R;
    • Powles, R;
    • Lentzsch, S;
    • Ming Chen, W;
    • Hou, J;
    • Jurczyszyn, A;
    • Romeril, K;
    • Hajek, R;
    • Terpos, E;
    • Shimizu, K;
    • Joshua, D;
    • Hungria, V;
    • Rodriguez Morales, A;
    • Ben-Yehuda, D;
    • Sondergeld, P;
    • Zamagni, E
    Publication type:
    Article
    50